Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: Mike M who wrote (46627)	2/4/2001 11:14:15 PM
From: velociraptor_	Read Replies (1) \| Respond to of 57584

Mike....I agree. The CEO of Celera, Craig Ventnor I believe, is quite ambitious. He accomplished the project of sequencing the human genome from scratch in much less than a year....and after the government has been funding a similar project for over 10 years now which is still not complete. They are trying to sequence at least 6 different genomes now, of different sexes and races to get a varied genome database. On top of that, I believe they are also trying to build a protein database as well. The potential for having the entire sequence info available will be incredible as they can possibly have numerous patent rights become available to them if the identify new genes. Currently, they are leasing out the information to Universities for research...Vanderbilt was the first to sign an agreement. Technically, CRA is now in a downtrend as with the rest of the market. Strong resistance is at 55, and then stronger resistance at 80. Below, support lines are at 37 3/4 (minor), 33 and then at 27 1/2. I would definitely be a buyer under 30 for something to stash away long term. Low 30's looks very possible right now, but no guarantees. I would also consider buying on a break of 55 with volume for a move towards 80, but only if the general market is showing strength too.